ANSM

The National Agency for the Safety of Medicines and Health Products (ANSM) is a pivotal public entity dedicated to ensuring public health in France. Established in 2011, ANSM facilitates access to essential health products while rigorously ensuring their safety throughout their entire lifecycle. The agency operates within the Government sector, serving as a critical interface for patients and healthcare professionals, fostering collaboration with their respective representatives. ANSM's mandate extends to overseeing a broad spectrum of health products, including vital medications, vaccines, and advanced medical devices, thereby safeguarding public well-being. The organization is committed to advancing therapeutic innovation and maintaining the highest standards of security for all health products under its purview. With a workforce of 500 - 1,000 employees, ANSM maintains a significant operational presence, and you can Meet ANSM's team to understand the expertise driving its mission. The agency manages operations across 2 locations, underscoring its structured approach to national health product regulation and oversight. ANSM actively supports clinical trials and implements robust safety monitoring systems, reinforcing its role as a guardian of health product integrity. Its strategic focus on promoting innovation ensures that France remains at the forefront of medical advancements, all while upholding stringent safety protocols. The agency's commitment to transparency and collaboration solidifies its position as a trusted authority in health product safety and accessibility.